271 related articles for article (PubMed ID: 10543276)
1. Surfactant abnormalities in idiopathic pulmonary fibrosis, hypersensitivity pneumonitis and sarcoidosis.
Günther A; Schmidt R; Nix F; Yabut-Perez M; Guth C; Rosseau S; Siebert C; Grimminger F; Morr H; Velcovsky HG; Seeger W
Eur Respir J; 1999 Sep; 14(3):565-73. PubMed ID: 10543276
[TBL] [Abstract][Full Text] [Related]
2. Elevated surfactant protein A in bronchoalveolar lavage fluids from sarcoidosis and hypersensitivity pneumonitis patients.
Hamm H; Lührs J; Guzman y Rotaeche J; Costabel U; Fabel H; Bartsch W
Chest; 1994 Dec; 106(6):1766-70. PubMed ID: 7988197
[TBL] [Abstract][Full Text] [Related]
3. KL-6, surfactant protein A and D in bronchoalveolar lavage fluid from patients with pulmonary sarcoidosis.
Kunitake R; Kuwano K; Yoshida K; Maeyama T; Kawasaki M; Hagimoto N; Hara N
Respiration; 2001; 68(5):488-95. PubMed ID: 11694811
[TBL] [Abstract][Full Text] [Related]
4. Surfactant alterations in severe pneumonia, acute respiratory distress syndrome, and cardiogenic lung edema.
Günther A; Siebert C; Schmidt R; Ziegler S; Grimminger F; Yabut M; Temmesfeld B; Walmrath D; Morr H; Seeger W
Am J Respir Crit Care Med; 1996 Jan; 153(1):176-84. PubMed ID: 8542113
[TBL] [Abstract][Full Text] [Related]
5. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A.
McCormack FX; King TE; Voelker DR; Robinson PC; Mason RJ
Am Rev Respir Dis; 1991 Jul; 144(1):160-6. PubMed ID: 2064123
[TBL] [Abstract][Full Text] [Related]
6. Loss of lymphocyte modulatory control by surfactant lipid extracts from acute hypersensitivity pneumonitis: comparison with sarcoidosis and idiopathic pulmonary fibrosis.
Lesur O; Mancini NM; Janot C; Chabot F; Boitout A; Polu JM; Gérard H
Eur Respir J; 1994 Nov; 7(11):1944-9. PubMed ID: 7875263
[TBL] [Abstract][Full Text] [Related]
7. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis.
McCormack FX; King TE; Bucher BL; Nielsen L; Mason RJ
Am J Respir Crit Care Med; 1995 Aug; 152(2):751-9. PubMed ID: 7633738
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
[TBL] [Abstract][Full Text] [Related]
9. Increased surfactant protein-A levels in patients with newly diagnosed idiopathic pulmonary fibrosis.
Phelps DS; Umstead TM; Mejia M; Carrillo G; Pardo A; Selman M
Chest; 2004 Feb; 125(2):617-25. PubMed ID: 14769746
[TBL] [Abstract][Full Text] [Related]
10. Surfactant subtype conversion is related to loss of surfactant apoprotein B and surface activity in large surfactant aggregates. Experimental and clinical studies.
Günther A; Schmidt R; Feustel A; Meier U; Pucker C; Ermert M; Seeger W
Am J Respir Crit Care Med; 1999 Jan; 159(1):244-51. PubMed ID: 9872845
[TBL] [Abstract][Full Text] [Related]
11. Increased surfactant protein A content in human alveolar macrophages in hypersensitivity pneumonitis.
Guzman J; Wang YM; Kalaycioglu O; Schoenfeld B; Hamm H; Bartsch W; Costabel U
Acta Cytol; 1992; 36(5):668-73. PubMed ID: 1523923
[TBL] [Abstract][Full Text] [Related]
12. Lung surfactant in a cystic fibrosis animal model: increased alveolar phospholipid pool size without altered composition and surface tension function in cftrm1HGU/m1HGU mice.
Bernhard W; Wang JY; Tschernig T; Tümmler B; Hedrich HJ; von der Hardt H
Thorax; 1997 Aug; 52(8):723-30. PubMed ID: 9337833
[TBL] [Abstract][Full Text] [Related]
13. Characterization of pulmonary surfactant protein D: its copurification with lipids.
Kuroki Y; Shiratori M; Ogasawara Y; Tsuzuki A; Akino T
Biochim Biophys Acta; 1991 Nov; 1086(2):185-90. PubMed ID: 1932100
[TBL] [Abstract][Full Text] [Related]
14. Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis.
Schmidt R; Ruppert C; Markart P; Lübke N; Ermert L; Weissmann N; Breithecker A; Ermert M; Seeger W; Günther A
Toxicol Appl Pharmacol; 2004 Mar; 195(2):218-31. PubMed ID: 14998687
[TBL] [Abstract][Full Text] [Related]
15. Human bronchoalveolar lavage fluid protein two-dimensional database: study of interstitial lung diseases.
Wattiez R; Hermans C; Cruyt C; Bernard A; Falmagne P
Electrophoresis; 2000 Jul; 21(13):2703-12. PubMed ID: 10949149
[TBL] [Abstract][Full Text] [Related]
16. Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis.
Greene KE; King TE; Kuroki Y; Bucher-Bartelson B; Hunninghake GW; Newman LS; Nagae H; Mason RJ
Eur Respir J; 2002 Mar; 19(3):439-46. PubMed ID: 11936520
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary surfactant in cystic fibrosis.
Griese M; Birrer P; Demirsoy A
Eur Respir J; 1997 Sep; 10(9):1983-8. PubMed ID: 9311489
[TBL] [Abstract][Full Text] [Related]
18. Alteration of fatty acid profiles in different pulmonary surfactant phospholipids in acute respiratory distress syndrome and severe pneumonia.
Schmidt R; Meier U; Yabut-Perez M; Walmrath D; Grimminger F; Seeger W; Günther A
Am J Respir Crit Care Med; 2001 Jan; 163(1):95-100. PubMed ID: 11208632
[TBL] [Abstract][Full Text] [Related]
19. Surface and tissue forces, surfactant protein A, and the phospholipid components of pulmonary surfactant in bleomycin-induced pulmonary fibrosis in the rat.
Horiuchi T; Mason RJ; Kuroki Y; Cherniack RM
Am Rev Respir Dis; 1990 Apr; 141(4 Pt 1):1006-13. PubMed ID: 1691603
[TBL] [Abstract][Full Text] [Related]
20. Altered phospholipid composition and aggregate structure of lung surfactant is associated with impaired lung function in young children with respiratory infections.
Mander A; Langton-Hewer S; Bernhard W; Warner JO; Postle AD
Am J Respir Cell Mol Biol; 2002 Dec; 27(6):714-21. PubMed ID: 12444031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
